
Global Non-opioid Analgesic Patch Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Non-opioid Analgesic Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Non-opioid Analgesic Patch market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Non-opioid Analgesic Patch market include Acorda Therapeutics, Inc, Allergan, Endo International plc, Hisamitsu Pharmaceutical Co.,Inc, IBSA Institut Biochimque SA, Teh Seng Pharmaceutical Mfg, Teikoku Seiyaku Co., Ltd., GlaxoSmithKline Plc and Pfizer, Inc., etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Non-opioid Analgesic Patch, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Non-opioid Analgesic Patch, also provides the value of main regions and countries. Of the upcoming market potential for Non-opioid Analgesic Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-opioid Analgesic Patch revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Non-opioid Analgesic Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Non-opioid Analgesic Patch company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Non-opioid Analgesic Patch Segment by Company
Acorda Therapeutics, Inc
Allergan
Endo International plc
Hisamitsu Pharmaceutical Co.,Inc
IBSA Institut Biochimque SA
Teh Seng Pharmaceutical Mfg
Teikoku Seiyaku Co., Ltd.
GlaxoSmithKline Plc
Pfizer, Inc.
Mylan N.V.
Non-opioid Analgesic Patch Segment by Type
Capsaicin Patches
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Ketoprofen Patches
Others
Non-opioid Analgesic Patch Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Non-opioid Analgesic Patch Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Non-opioid Analgesic Patch status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Non-opioid Analgesic Patch key companies, revenue, market share, and recent developments.
3. To split the Non-opioid Analgesic Patch breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Non-opioid Analgesic Patch market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Non-opioid Analgesic Patch significant trends, drivers, influence factors in global and regions.
6. To analyze Non-opioid Analgesic Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Analgesic Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Analgesic Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Analgesic Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-opioid Analgesic Patch industry.
Chapter 3: Detailed analysis of Non-opioid Analgesic Patch company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Non-opioid Analgesic Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Non-opioid Analgesic Patch in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Non-opioid Analgesic Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Non-opioid Analgesic Patch market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Non-opioid Analgesic Patch market include Acorda Therapeutics, Inc, Allergan, Endo International plc, Hisamitsu Pharmaceutical Co.,Inc, IBSA Institut Biochimque SA, Teh Seng Pharmaceutical Mfg, Teikoku Seiyaku Co., Ltd., GlaxoSmithKline Plc and Pfizer, Inc., etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Non-opioid Analgesic Patch, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Non-opioid Analgesic Patch, also provides the value of main regions and countries. Of the upcoming market potential for Non-opioid Analgesic Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-opioid Analgesic Patch revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Non-opioid Analgesic Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Non-opioid Analgesic Patch company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Non-opioid Analgesic Patch Segment by Company
Acorda Therapeutics, Inc
Allergan
Endo International plc
Hisamitsu Pharmaceutical Co.,Inc
IBSA Institut Biochimque SA
Teh Seng Pharmaceutical Mfg
Teikoku Seiyaku Co., Ltd.
GlaxoSmithKline Plc
Pfizer, Inc.
Mylan N.V.
Non-opioid Analgesic Patch Segment by Type
Capsaicin Patches
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Ketoprofen Patches
Others
Non-opioid Analgesic Patch Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Non-opioid Analgesic Patch Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Non-opioid Analgesic Patch status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Non-opioid Analgesic Patch key companies, revenue, market share, and recent developments.
3. To split the Non-opioid Analgesic Patch breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Non-opioid Analgesic Patch market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Non-opioid Analgesic Patch significant trends, drivers, influence factors in global and regions.
6. To analyze Non-opioid Analgesic Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Analgesic Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Analgesic Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Analgesic Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-opioid Analgesic Patch industry.
Chapter 3: Detailed analysis of Non-opioid Analgesic Patch company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Non-opioid Analgesic Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Non-opioid Analgesic Patch in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
193 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Non-opioid Analgesic Patch Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Non-opioid Analgesic Patch Market Size (2020-2031)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Non-opioid Analgesic Patch Market Dynamics
- 2.1 Non-opioid Analgesic Patch Industry Trends
- 2.2 Non-opioid Analgesic Patch Industry Drivers
- 2.3 Non-opioid Analgesic Patch Industry Opportunities and Challenges
- 2.4 Non-opioid Analgesic Patch Industry Restraints
- 3 Non-opioid Analgesic Patch Market by Company
- 3.1 Global Non-opioid Analgesic Patch Company Revenue Ranking in 2024
- 3.2 Global Non-opioid Analgesic Patch Revenue by Company (2020-2025)
- 3.3 Global Non-opioid Analgesic Patch Company Ranking (2023-2025)
- 3.4 Global Non-opioid Analgesic Patch Company Manufacturing Base and Headquarters
- 3.5 Global Non-opioid Analgesic Patch Company Product Type and Application
- 3.6 Global Non-opioid Analgesic Patch Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Non-opioid Analgesic Patch Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.7.3 2024 Non-opioid Analgesic Patch Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
- 4 Non-opioid Analgesic Patch Market by Type
- 4.1 Non-opioid Analgesic Patch Type Introduction
- 4.1.1 Capsaicin Patches
- 4.1.2 Lidocaine Patches
- 4.1.3 Diclofenac Patches
- 4.1.4 Methyl Salicylate Patches
- 4.1.5 Ketoprofen Patches
- 4.1.6 Others
- 4.2 Global Non-opioid Analgesic Patch Sales Value by Type
- 4.2.1 Global Non-opioid Analgesic Patch Sales Value by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Non-opioid Analgesic Patch Sales Value by Type (2020-2031)
- 4.2.3 Global Non-opioid Analgesic Patch Sales Value Share by Type (2020-2031)
- 5 Non-opioid Analgesic Patch Market by Application
- 5.1 Non-opioid Analgesic Patch Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Independent Pharmacies & Drug Stores
- 5.2 Global Non-opioid Analgesic Patch Sales Value by Application
- 5.2.1 Global Non-opioid Analgesic Patch Sales Value by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Non-opioid Analgesic Patch Sales Value by Application (2020-2031)
- 5.2.3 Global Non-opioid Analgesic Patch Sales Value Share by Application (2020-2031)
- 6 Non-opioid Analgesic Patch Regional Value Analysis
- 6.1 Global Non-opioid Analgesic Patch Sales Value by Region: 2020 VS 2024 VS 2031
- 6.2 Global Non-opioid Analgesic Patch Sales Value by Region (2020-2031)
- 6.2.1 Global Non-opioid Analgesic Patch Sales Value by Region: 2020-2025
- 6.2.2 Global Non-opioid Analgesic Patch Sales Value by Region (2026-2031)
- 6.3 North America
- 6.3.1 North America Non-opioid Analgesic Patch Sales Value (2020-2031)
- 6.3.2 North America Non-opioid Analgesic Patch Sales Value Share by Country, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Non-opioid Analgesic Patch Sales Value (2020-2031)
- 6.4.2 Europe Non-opioid Analgesic Patch Sales Value Share by Country, 2024 VS 2031
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Non-opioid Analgesic Patch Sales Value (2020-2031)
- 6.5.2 Asia-Pacific Non-opioid Analgesic Patch Sales Value Share by Country, 2024 VS 2031
- 6.6 South America
- 6.6.1 South America Non-opioid Analgesic Patch Sales Value (2020-2031)
- 6.6.2 South America Non-opioid Analgesic Patch Sales Value Share by Country, 2024 VS 2031
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Non-opioid Analgesic Patch Sales Value (2020-2031)
- 6.7.2 Middle East & Africa Non-opioid Analgesic Patch Sales Value Share by Country, 2024 VS 2031
- 7 Non-opioid Analgesic Patch Country-level Value Analysis
- 7.1 Global Non-opioid Analgesic Patch Sales Value by Country: 2020 VS 2024 VS 2031
- 7.2 Global Non-opioid Analgesic Patch Sales Value by Country (2020-2031)
- 7.2.1 Global Non-opioid Analgesic Patch Sales Value by Country (2020-2025)
- 7.2.2 Global Non-opioid Analgesic Patch Sales Value by Country (2026-2031)
- 7.3 USA
- 7.3.1 USA Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.3.2 USA Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.3.3 USA Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.4 Canada
- 7.4.1 Canada Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.4.2 Canada Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.4.3 Canada Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.5 Mexico
- 7.5.1 Mexico Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.5.2 Mexico Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.5.3 Mexico Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.6 Germany
- 7.6.1 Germany Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.6.2 Germany Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Germany Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.7 France
- 7.7.1 France Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.7.2 France Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.7.3 France Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.8 U.K.
- 7.8.1 U.K. Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.8.2 U.K. Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.8.3 U.K. Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.9 Italy
- 7.9.1 Italy Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.9.2 Italy Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.9.3 Italy Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.10 Spain
- 7.10.1 Spain Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.10.2 Spain Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.10.3 Spain Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.11 Russia
- 7.11.1 Russia Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.11.2 Russia Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Russia Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.12 Netherlands
- 7.12.1 Netherlands Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.12.2 Netherlands Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Netherlands Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.13.2 Nordic Countries Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Nordic Countries Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.14 China
- 7.14.1 China Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.14.2 China Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.14.3 China Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.15 Japan
- 7.15.1 Japan Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.15.2 Japan Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Japan Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.16 South Korea
- 7.16.1 South Korea Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.16.2 South Korea Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.16.3 South Korea Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.17 India
- 7.17.1 India Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.17.2 India Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.17.3 India Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.18 Australia
- 7.18.1 Australia Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.18.2 Australia Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.18.3 Australia Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.19.2 Southeast Asia Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.19.3 Southeast Asia Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.20 Brazil
- 7.20.1 Brazil Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.20.2 Brazil Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Brazil Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.21 Argentina
- 7.21.1 Argentina Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.21.2 Argentina Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Argentina Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.22 Chile
- 7.22.1 Chile Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.22.2 Chile Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Chile Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.23 Colombia
- 7.23.1 Colombia Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.23.2 Colombia Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Colombia Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.24 Peru
- 7.24.1 Peru Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.24.2 Peru Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Peru Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.25.2 Saudi Arabia Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Saudi Arabia Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.26 Israel
- 7.26.1 Israel Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.26.2 Israel Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Israel Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.27 UAE
- 7.27.1 UAE Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.27.2 UAE Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.27.3 UAE Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.28 Turkey
- 7.28.1 Turkey Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.28.2 Turkey Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Turkey Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.29 Iran
- 7.29.1 Iran Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.29.2 Iran Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.29.3 Iran Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 7.30 Egypt
- 7.30.1 Egypt Non-opioid Analgesic Patch Sales Value Growth Rate (2020-2031)
- 7.30.2 Egypt Non-opioid Analgesic Patch Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Egypt Non-opioid Analgesic Patch Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Acorda Therapeutics, Inc
- 8.1.1 Acorda Therapeutics, Inc Comapny Information
- 8.1.2 Acorda Therapeutics, Inc Business Overview
- 8.1.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.1.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio
- 8.1.5 Acorda Therapeutics, Inc Recent Developments
- 8.2 Allergan
- 8.2.1 Allergan Comapny Information
- 8.2.2 Allergan Business Overview
- 8.2.3 Allergan Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.2.4 Allergan Non-opioid Analgesic Patch Product Portfolio
- 8.2.5 Allergan Recent Developments
- 8.3 Endo International plc
- 8.3.1 Endo International plc Comapny Information
- 8.3.2 Endo International plc Business Overview
- 8.3.3 Endo International plc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.3.4 Endo International plc Non-opioid Analgesic Patch Product Portfolio
- 8.3.5 Endo International plc Recent Developments
- 8.4 Hisamitsu Pharmaceutical Co.,Inc
- 8.4.1 Hisamitsu Pharmaceutical Co.,Inc Comapny Information
- 8.4.2 Hisamitsu Pharmaceutical Co.,Inc Business Overview
- 8.4.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.4.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio
- 8.4.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
- 8.5 IBSA Institut Biochimque SA
- 8.5.1 IBSA Institut Biochimque SA Comapny Information
- 8.5.2 IBSA Institut Biochimque SA Business Overview
- 8.5.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.5.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio
- 8.5.5 IBSA Institut Biochimque SA Recent Developments
- 8.6 Teh Seng Pharmaceutical Mfg
- 8.6.1 Teh Seng Pharmaceutical Mfg Comapny Information
- 8.6.2 Teh Seng Pharmaceutical Mfg Business Overview
- 8.6.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.6.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio
- 8.6.5 Teh Seng Pharmaceutical Mfg Recent Developments
- 8.7 Teikoku Seiyaku Co., Ltd.
- 8.7.1 Teikoku Seiyaku Co., Ltd. Comapny Information
- 8.7.2 Teikoku Seiyaku Co., Ltd. Business Overview
- 8.7.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.7.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio
- 8.7.5 Teikoku Seiyaku Co., Ltd. Recent Developments
- 8.8 GlaxoSmithKline Plc
- 8.8.1 GlaxoSmithKline Plc Comapny Information
- 8.8.2 GlaxoSmithKline Plc Business Overview
- 8.8.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.8.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio
- 8.8.5 GlaxoSmithKline Plc Recent Developments
- 8.9 Pfizer, Inc.
- 8.9.1 Pfizer, Inc. Comapny Information
- 8.9.2 Pfizer, Inc. Business Overview
- 8.9.3 Pfizer, Inc. Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.9.4 Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio
- 8.9.5 Pfizer, Inc. Recent Developments
- 8.10 Mylan N.V.
- 8.10.1 Mylan N.V. Comapny Information
- 8.10.2 Mylan N.V. Business Overview
- 8.10.3 Mylan N.V. Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
- 8.10.4 Mylan N.V. Non-opioid Analgesic Patch Product Portfolio
- 8.10.5 Mylan N.V. Recent Developments
- 9 Concluding Insights
- 10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.